Who makes Pancrelipase microtablets?

Pancrelipase microtablets is developed by McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc..

What development phase is Pancrelipase microtablets in?

Pancrelipase microtablets is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Pancrelipase microtablets

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. · Phase 2 active Small molecule

At a glance

Generic name	Pancrelipase microtablets
Sponsor	McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pancrelipase microtablets CI brief — competitive landscape report
Pancrelipase microtablets updates RSS · CI watch RSS
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. portfolio CI